MedTrace Logo

Mode Selection Trial in Sinus Node Dysfunction (MOST)

NCT00000561 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2016-02-23

No results posted yet for this study

Summary

To determine if dual chamber rate-modulated pacing (DDDR) in patients with sick sinus syndrome is superior to single chamber pacing (VVIR) with respect to subsequent frequency of adverse clinical events such as stroke, quality of life and function, and cost effectiveness.

Conditions

Interventions

DEVICE

pacemaker, artificial

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Mt. Sinai Medical Center, Miami

    lead OTHER

Principal Investigators

  • Gervasio Lamas · Icahn School of Medicine at Mount Sinai

  • Kerry Lee · Duke University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1995-06-30
Completion
2002-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000561 on ClinicalTrials.gov